David O'Dwyer, MD, PhD

 David O Dwyer
Associate Professor of Internal Medicine
Associate Professor of Microbiology and Immunology
Medical School
Email:
[email protected]
Available to mentor
David O'Dwyer, MD, PhD
David O Dwyer
Associate Professor
  • About
  • Qualifications
  • Recent Publications

  • Manage Your Profile

    • About

    Dr. O’Dwyer is an Associate Professor in the Division of Pulmonary and Critical Care Medicine at the University of Michigan. He graduated from University College Cork Medical School, National University of Ireland in 2004. Dr. O’Dwyer completed his internal medicine residency training through the Royal College of Surgeons of Ireland and was awarded membership of the Royal College of Physicians (RCPI) in 2007. He completed a clinical fellowship in internal medicine and pulmonary medicine at St. Vincents University Hospital and the Royal College of Physicians in 2014. He completed research training in pulmonary medicine graduating with a PhD in pulmonary fibrosis from University College Dublin, National University of Ireland in 2014. He completed clinical fellowship training in pulmonary and critical care medicine at the University of Michigan in 2017.

    Qualifications
    • PhD
      University College Dublin, NUI, National University of Ireland Stillorgan Road, Dublin, Ireland
      2010 - 2014
    • MB BCH BAO
      University College Cork School of Medicine, National University of Ireland (NUI), National University of Ireland Room 2.59, Brookfield Health Sciences Complex, College Road, Cork, Ireland
      1998 - 2004

    Recent Publications

     See All Publications
    • Journal Article
      Survival According to Radiomic and Visual UIP Classification in Fibrotic ILD.
      Wang JM, Pugashetti JV, Thompson J, Kang E, Kazerooni EA, Flaherty KR, Belloli EA, Sheth JS, O'Dwyer DN, Han MK, Hatt CR, Oldham JM, Chung JH. Chest, 2026 Aug 12; DOI:10.1016/j.chest.2026.08.002
      PMID: 42586496
    • Journal Article
      Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and TLR5 deficiency is associated with human IPF
      Sakamachi O, Wiley E, Trempus CS, Jacobs H, Solis A, Johnson CG, Meng X, Hussain S, Roselli A, Lipinski JH, O’dwyer DN, Randall TA, Malphurs J, Papas B, Wu BG, Li Y, Kugler MC, Mehta S, Scappini E, Thomas SY, Li JL, Zhou L, Karmaus PW, Lih FB, Fessler MB, Mcgrath JA, Gibson K, Kass DJ, Gleiberman A, Andrianova E, Walts A, Invernizzi R, Molyneaux PL, Yang IV, Zhang Y, Kaminski N, Segal LN, Schwartz DA, Gudkov AV, Garantziotis S. Science Translational Medicine, 2026 Jun 3; 18 (852): eadw1028 DOI:10.1126/scitranslmed.adw1028
      PMID: 42234773
    • Journal Article
      Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosis.
      Kim JS, Loe A, Ma S-F, Ranjan P, Lipinski JH, Mikhail SG, Gurczynski SJ, Zhou X, Huffnagle GB, Downward JE, Metcalf JD, Falkowski N, Stringer KA, Dickson RP, Huang Y, Moore BB, Martinez FJ, Murray S, Noth I, O'Dwyer DN. Am J Respir Crit Care Med, 2026 May 19; DOI:10.1093/ajrccm/aamag249
      PMID: 42155010
    • Journal Article
      A15-05 Screening for Interstitial Lung Disease Using Quantitative CT Thresholds
      Wang JM, Pugashetti JV, Murray S, Mohan N, Kang E, Kazerooni E, Flaherty KR, Belloli E, Sheth JS, O’Dwyer DN, Han MK, Hatt CR, Oldham J. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.2203 DOI:10.1093/ajrccm/aamag162.2203
    • Journal Article
      A22-03 IL-10 Receptor Alpha Mediates Protection From Bleomycin Induced Fibrosis in Mice Housed in Thermoneutrality
      Mikhail S, Lipinski J, Zhai X, Ranjan P, Rasky A, Hock T, Ganesan V, Denstaedt SJ, Lukacs NW, Zhou X, Gurczynski SJ, Cable D, Hogan S, Moore BB, O’Dwyer DN. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.2208 DOI:10.1093/ajrccm/aamag162.2208
    • Journal Article
      Abstract 2378 Isolation and Characterization of Novel Streptococcal species from the oral mucosa of a patient with Idiopathic Pulmonary Fibrosis (IPF)
      Klauza S, Pickelner S, Ntamubano S, Falkowski N, Mohan N, Lipinksi J, Oldham J, O'Dwyer D, Kozik A. Journal of Biological Chemistry, 2026 May 22; 302 (5): 112304 DOI:10.1016/j.jbc.2026.112304
    • Journal Article
      B23-09 Comparing Survival Outcomes Between Radiomic UIP and Visual UIP Classification in Fibrotic ILD
      Wang JM, Pugashetti JV, Murray S, Mohan N, Kang E, Kazerooni E, Flaherty KR, Belloli E, Sheth JS, O’Dwyer DN, Han MK, Hatt CR, Oldham J. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.2446 DOI:10.1093/ajrccm/aamag162.2446
    • Journal Article
      Characteristics of severe disease in GL-ILD: a retrospective cohort study
      Bongers KS, Massett A, Patel SV, Konopka KE, Nagaraja V, Wang BR, Kovalszki A, O'Dwyer DN. ERJ Open Research, 2026 Feb 18; 01617 - 02025. DOI:10.1183/23120541.01617-2025